Skip to content

Observing Physiological Changes in Patients With Long-term Oxygen Therapy

Observing Physiological Changes in Patients With Long-term Oxygen Therapy Via Optical and Accelerometry Signals

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06525857
Enrollment
40
Registered
2024-07-29
Start date
2024-06-01
Completion date
2026-01-31
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Disease

Brief summary

In this project, the investigators aim to assess changes of physiological parameters obtained non-invasively through PPG and accelerometry signals between before and during LTOT (long-term oxygen therapy) and investigate if those changes are different in patients with worsening frailty and/or improving quality of life. For this, they will record optical (PPG) and accelerometry data via a datalogger on 40 patients undergoing LTOT and assess the PPG-derived physiological signals.

Interventions

OTHERLTOT

Patients with newly prescribed LTOT will be monitored for physiological changes

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18-year-old, and * Chronic respiratory disease including a) chronic obstructive pulmonary disease, b) interstitial lung disease, c) pulmonary hypertension, d) bronchiectasis, and * Prescribed new LTOT due to a chronic respiratory disease with resting and/or exertional hypoxemia, and * Able to speak/read/understand German or French, and * Willing and able to understand and provide signed informed consent

Exclusion criteria

* Pregnant or lactating women, or * Inability to follow the procedures/instructions of the study (e.g. due to language, psychological disorders, dementia, etc.), or * Patients having a subordination link to the investigators, or * Patients with isolated nocturnal oxygen therapy or LTOT prescription for a heart disease, sleep associated breathing disorder, neuromuscular disease or lung cancer, or * Known participation in another human research project (ClinO/HRO) that may affect the objectives of this study.

Design outcomes

Primary

MeasureTime frameDescription
Heart rate changes from before and during LTOTFrom 1 week before start of LTOT to 1 month after start of LTOTRecord heart rate (BPM) to compare before and during LTOT
Respiratory rate changes from before and during LTOTFrom 1 week before start of LTOT to 1 month after start of LTOTRecord respiratory rate (breaths per minute) to compare before and during LTOT
SpO2 changes from before and during LTOTFrom 1 week before start of LTOT to 1 month after start of LTOTRecord SpO2 (%) to compare before and during LTOT

Countries

Switzerland

Contacts

Primary ContactSabina Guler, PD Dr. med.
sabina.guler@insel.ch+41 31 66 4 48 92

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026